ENOV PB Ratio
0.77×TTM
Retrieved:
ENOV FY P/B Ratio
54.24×-44.33×
2004-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
ENOV pb ratio history
Price-to-book ratio. The available annual fiscal periods series contains 22 observations from Dec 31, 2004 to Dec 31, 2025.
| Period ending | PB Ratio |
|---|---|
| 1.0156× | |
| 0.9467× | |
| 0.8931× | |
| 0.8392× | |
| 0.8763× | |
| 0.8468× | |
| 0.8231× | |
| 0.4411× | |
| 0.7977× | |
| 0.8766× | |
| 0.5422× | |
| 1.1374× | |
| 1.4582× | |
| 1.0968× | |
| 3.8216× | |
| 2.1393× | |
| 1.5093× | |
| 1.1999× | |
| 4.9704× | |
| 44.7001× | |
| -34.7916× | |
| 2.6882× |
Compare pb ratio
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) pb ratio
- Bridgebio Pharma Inc (BBIO) pb ratio
- Brightspring Health Services Inc (BTSG) pb ratio
- Madrigal Pharmaceuticals Inc (MDGL) pb ratio
- Ensign Group Inc (ENSG) pb ratio
- Glaukos Corp (GKOS) pb ratio
- Vaxcyte Inc (PCVX) pb ratio
- Krystal Biotech Inc (KRYS) pb ratio
Compare all covered stocks by pb ratio →
All ENOV financial metrics · ENOV stock overview · How to interpret financial metrics